DocDollars

Abbvie Inc.

IL · United States · Reporting entity ID 100000000204

Total reported 2019–2025
$2.95B
#7 of 2,960 reporting companies — 3.5% of all reported industry payments
$874.5M in general payments across 8,598,681 records, plus $2.07B in research funding across 257,815 records.

How it breaks down

General payments $874,461,854
Research funding $2,074,838,552

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Abbvie Inc. reported $2.95B to US doctors and teaching hospitals from 2019 to 2025, ranking #7 of 2,960 reporting companies. 70% of that was research funding and 30% general payments such as consulting, speaking, food and travel. 8,598,681 general payment records and 257,815 research records were filed.

Common questions about Abbvie Inc.

How much has Abbvie Inc. paid US doctors?

Abbvie Inc. reported $2,949,300,407 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $874,461,854 in general payments, $2,074,838,552 in research funding.

How does Abbvie Inc. rank among drug and device companies?

It ranks #7 of 2,960 reporting entities by total reported value, about 3.5% of all industry payments in the dataset.

Does a payment from Abbvie Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.